FDA Approves First ProAir HFA Generic

March 4, 2020

FDA Approves First ProAir HFA Generic

The U.S. FDA has announced its approval of the first generic of ProAir HFA (albuterol sulfate), one of the most commonly used metered-dose rescue inhalers. Generating similar generic copies of complex drugs on the market will help get these life-saving drugs into patients’ hands at lower costs. With all of the cost pressures affecting patients and the industry today, Yourway is enthusiastic about any measures that reduce healthcare costs.

Back to Index

Media

Upcoming Event

11th Annual Clinical Trials Summit 2020

May 28, 2020
Kohinoor Continental Hotel, Mumbai, India
Booth #4

Schedule a Meeting

Media

Articles

SUPPLY CHAIN SOLUTIONS – Storage and Distribution Support for Clinical Trials Worldwide

Open chat

Hello! How can I help you?